Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical Trials
Debiopharm Innovation Fund and Benchstrength co-lead seed funding round supporting Altis’ AI-powered imaging biomarker platformTORONTO & LAUSANNE, Switzerland & NEW YORK--(BUSINESS WIRE)--Altis Labs, Inc. (“Altis”), the computational imaging company a...